Search
× Search

Baza informacij za delovanje Partnerjev Mreže Modro Poslovanje

0 0

CELEX:62024TJ0428:           Arrêt du Tribunal (dixième chambre) du 17 juin 2026.#République portugaise contre Commission européenne.#FEAGA et Feader – Dépenses exclues du financement – Dépenses effectuées par le Portugal – Période de rétention – Remplacement d’animaux – Modalités de calcul de l’augmentation du taux de contrôle sur place – Éléments de preuve du doute sérieux et raisonnable.#Affaire T-428/24.

This document does not exist in English.
0 0

CELEX:62024TJ0429:           Arrêt du Tribunal (troisième chambre) du 2 avril 2025.#Paul Hartmann AG contre Office de l’Union européenne pour la propriété intellectuelle.#Marque de l’Union européenne – Procédure de nullité – Enregistrement international désignant l’Union européenne – Marque verbale MEDISET – Cause de nullité absolue – Absence de caractère distinctif – Caractère descriptif – Article 7, paragraphe 1, sous b) et c), du règlement (CE) no 40/94 [devenu article 7, paragraphe 1, sous b) et c), du règlement (UE) 2017/1001].#Affaire T-429/24.

This document does not exist in English.
0 0

CELEX:62024TJ0432: Judgment of the General Court (Second Chamber) of 23 July 2025.#Glaxo Group Ltd v European Union Intellectual Property Office.#EU trade mark – Invalidity proceedings – Three-dimensional EU trade mark – Shape of an inhaler – Absolute ground for invalidity – No distinctive character – Article 7(1)(b) and Article 51(1)(a) of Regulation (EC) No 40/94 – No distinctive character acquired through use – Article 7(3) and Article 51(2) of Regulation No 40/94 – Decision adopted following the annulment by the General Court of an earlier decision – Res judicata – Article 72(6) of Regulation (EU) 2017/1001 – Obligation to state reasons – Article 94(1) of Regulation 2017/1001.#Case T-432/24.

0 0

CELEX:62024TJ0432_INF: Judgment of the General Court (Second Chamber) of 23 July 2025.#Glaxo Group Ltd v European Union Intellectual Property Office.#EU trade mark – Invalidity proceedings – Three-dimensional EU trade mark – Shape of an inhaler – Absolute ground for invalidity – No distinctive character – Article 7(1)(b) and Article 51(1)(a) of Regulation (EC) No 40/94 – No distinctive character acquired through use – Article 7(3) and Article 51(2) of Regulation No 40/94 – Decision adopted following the annulment by the General Court of an earlier decision – Res judicata – Article 72(6) of Regulation (EU) 2017/1001 – Obligation to state reasons – Article 94(1) of Regulation 2017/1001.#Case T-432/24.

0 0

CELEX:62024TJ0433: Judgment of the General Court (First Chamber) of 25 February 2026.#Edward William Batchelor v European Commission.#Access to documents – Regulation (EC) No 1049/2001 – Regulation (EU) 2022/1925 – Documents relating to designation as a gatekeeper – Refusal of access – Obligation to state reasons – Exception relating to the protection of court proceedings – Exception relating to the protection of the purpose of inspections, investigations and audits – Overriding public interest – Obligation to state reasons.#Case T-433/24.

RSS
First28262827282828292831283328342835Last

Poišči članke o davkih v bazi Modro poslovanje

Terms Of UsePrivacy StatementCopyright 2014-2014 by Srobotnik d.o.o.
Back To Top